ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $862K of Zentalis Pharmaceuticals, Inc.
Sold$861,856
$46.92Price
18,370Shares
−4%Stake
What ZNTL did after the filing
- The stock from Thu, Jul 8 close, $50.33
- +3.5%
- S&P 500, same days
- +2.1%
Measured over 30 trading days, to the Aug 19 close.
Traded Tue, Jul 6. Filed Thu, Jul 8, 12:55 PM ET, during the session. Returns use the Jul 8 close and the Aug 19 close. Not investment advice.